All research
2026-04-03 PubMed

Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells.


Summary withdrawn

TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.


mia-602 ghrh-antagonist inflammation covid-19 sars-cov-2 macrophages
Source: pubmed:37649486 · Ingested Apr 3, 2026